Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice

Layegh, Z; Ruwaard, J; Hebing, RCF; l' Ami, MJ; van der Weele, W; Nurmohamed, MT; Krieckaert, C; Wolbink, G

Layegh, Z (reprint author), Reade, Amsterdam Rheumatol & Immunol Ctr, Rheumatol, Amsterdam, Netherlands.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019; 22 (5): 869

Abstract

Objectives To evaluate the transition from reference infliximab Remicade to biosimilar Remsima in patients with rheumatoid arthritis (RA) or psoriatic......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索